01.07.2024 08:11:48 - dpa-AFX: *AZN : LYNPARZA AND IMFINZI COMBINATION RECOMMENDED FOR APPROVAL IN EU BY CHMP FOR RECURRENT ENDOMETRIAL CANCER

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
ASTRAZENECA PLC DL-,25 886455 Xetra 150,050 14.08.24 16:00:06 -1,850 -1,22% 150,000 150,200 151,950 151,900

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH